newsfilter
← Latest News
Business Wire·

ReCode Therapeutics Appoints Julie Eastland as Chief Operating Officer and Chief Financial Officer

MENLO PARK, Calif. & DALLAS--(BUSINESS WIRE)--ReCode Therapeutics™ (ReCode) (the Company), a private biopharmaceutical company pioneering disease-modifying medicines for the treatment of life-limiting respiratory diseases, today announced the appointment of Julie Eastland as chief operating officer (COO) and chief financial officer (CFO). Eastland will oversee the company’s financial and business operations.